首页> 外文OA文献 >The effect of probiotics and zinc supplementation on the immune response to oral rotavirus vaccine: A randomized, factorial design, placebo-controlled study among Indian infants
【2h】

The effect of probiotics and zinc supplementation on the immune response to oral rotavirus vaccine: A randomized, factorial design, placebo-controlled study among Indian infants

机译:益生菌和补锌对口服轮状病毒疫苗免疫应答的影响:印度婴儿的随机,因子设计,安慰剂对照研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background Strategies are needed to improve oral rotavirus vaccine (RV), which provides suboptimal protection in developing countries. Probiotics and zinc supplementation could improve RV immunogenicity by altering the intestinal microbiota and immune function. Methods Infants 5 weeks old living in urban Vellore, India were enrolled in a randomized, double-blind, placebo-controlled trial with a 4-arm factorial design to assess the effects of daily zinc (5 mg), probiotic (1010 Lactobacillus rhamnosus GG) or placebo on the immunogenicity of two doses of RV (Rotarix®, GlaxoSmithKline Biologicals) given at 6 and 10 weeks of age. Infants were eligible for participation if healthy, available for the study duration and without prior receipt of RV or oral poliovirus vaccine other than the birth dose. The primary outcome was seroconversion to rotavirus at 14 weeks of age based on detection of VP6-specific IgA at ≥20 U/ml in previously seronegative infants or a fourfold rise in concentration. Results The study took place during July 2012 to February 2013. 620 infants were randomized equally between study arms and 551 (88.9%) completed per protocol. Seroconversion was recorded in 54/137 (39.4%), 42/136 (30.9%), 40/143 (28.0%), and 37/135 (27.4%) infants receiving (1) probiotic and zinc, (2) probiotic and placebo, (3) placebo and zinc, (4) two placebos. Seroconversion showed a modest improvement among infants receiving probiotic (difference between groups 1, 2 and 3, 4 was 7.5% (97.5% Confidence Interval (CI): −1.4%, 16.2%), p = 0.066) but not zinc (difference between groups 1, 3 and 2, 4 was 4.4% (97.5% CI: −4.4%, 13.2%), p = 0.272). 16 serious adverse events were recorded, none related to study interventions. Conclusions Zinc or probiotic supplementation did not significantly improve the low immunogenicity of rotavirus vaccine given to infants in a poor urban community in India. A modest effect of combined supplementation deserves further investigation.
机译:背景技术需要改善口服轮状病毒疫苗(RV)的策略,该疫苗在发展中国家提供的保护作用欠佳。益生菌和补锌可以通过改变肠道菌群和免疫功能来改善RV的免疫原性。方法研究生活在印度Vellore的5周大的婴儿,进行了一项随机,双盲,安慰剂对照试验,该试验采用4组因子分析设计,以评估每日锌(5 mg),益生菌(1010鼠李糖乳杆菌GG)的作用)或安慰剂对6和10周龄的两剂RV(Rotarix®,葛兰素史克Biologicals)的免疫原性。如果婴儿健康,在研究期间可用且未事先接受RV或口服脊髓灰质炎病毒疫苗(出生剂量除外),则符合参加的资格。主要结果是根据先前血清阴性婴儿中≥20 U / ml的VP6特异性IgA的检测或浓度升高四倍,在14周龄时血清型转化为轮状病毒。结果研究于2012年7月至2013年2月进行。根据研究方案,将620例婴儿平均分为研究组,完成551例(88.9%)。接受(1)益生菌和锌,(2)益生菌和锌的54/137(39.4%),42/136(30.9%),40/143(28.0%)和37/135(27.4%)婴儿发生血清转化。安慰剂,(3)安慰剂和锌,(4)两个安慰剂。血清转化显示,接受益生菌的婴儿适度改善(1、2、3、4组之间的差异为7.5%(97.5%置信区间(CI):− 1.4%,16.2%),p = 0.066),而不是锌(两者之间的差异组1,3和2,4为4.4%(97.5%CI:-4.4%,13.2%,p = 0.272)。记录了16个严重不良事件,与研究干预措施无关。结论补充锌或益生菌并不能显着改善印度贫困城市婴儿的轮状病毒疫苗的低免疫原性。联合补充的适度效果值得进一步研究。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号